img

Global Pharmaceutical Development Preclinical CRO Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Pharmaceutical Development Preclinical CRO Market Insights, Forecast to 2034

A preclinical CRO (contract research organizations) helps new medical product developers (including devices, drugs, biologics and more) prove those products are safe and effective in live models the FDA deems approximate as closely as possible the human anatomy prior to those devices enter clinical trials (or receiving other approvals like 510Ks) or use for human care. Pharmaceutical companies invest lots of money to research and produce drugs/medicines for patients. Patients and healthcare providers (doctors, nurses, hospitals, nursing homes, clinics, etc.) are all dependent on these companies for the treatment of diseases.
Market Analysis and InsightsGlobal Pharmaceutical Development Preclinical CRO Market
Global Pharmaceutical Development Preclinical CRO market is expected to reach to US$ 12530 million in 2023, with a positive growth of %, compared with US$ 11540 million in 2022. Backed with the increasing demand from downstream industries, Pharmaceutical Development Preclinical CRO industry is evaluated to reach US$ 19890 million in 2033. The CAGR will be 8.0% during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Pharmaceutical Development Preclinical CRO market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Pharmaceutical Development Preclinical CRO market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Charles River
Wuxi AppTec
Labcorp
Eurofins Scientific
PPD, Inc.
ICON Plc.
Pharmaron
Inotiv
ChemPartner
JOINN Lab
EVOTEC
Medicilon
Crown Bioscience
Champion Oncology
Segment by Type
Bioanalysis and DMPK Studies
Toxicology Testing
Safety Pharmacology
Others

Segment by Application


Small and Medium Pharmaceutical Company
Large Pharmaceutical Company
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Pharmaceutical Development Preclinical CRO introduction, etc. Pharmaceutical Development Preclinical CRO Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Pharmaceutical Development Preclinical CRO
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Development Preclinical CRO Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Bioanalysis and DMPK Studies
1.2.3 Toxicology Testing
1.2.4 Safety Pharmacology
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pharmaceutical Development Preclinical CRO Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Small and Medium Pharmaceutical Company
1.3.3 Large Pharmaceutical Company
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Development Preclinical CRO Market Perspective (2018-2033)
2.2 Global Pharmaceutical Development Preclinical CRO Growth Trends by Region
2.2.1 Pharmaceutical Development Preclinical CRO Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Pharmaceutical Development Preclinical CRO Historic Market Size by Region (2018-2023)
2.2.3 Pharmaceutical Development Preclinical CRO Forecasted Market Size by Region (2024-2033)
2.3 Pharmaceutical Development Preclinical CRO Market Dynamics
2.3.1 Pharmaceutical Development Preclinical CRO Industry Trends
2.3.2 Pharmaceutical Development Preclinical CRO Market Drivers
2.3.3 Pharmaceutical Development Preclinical CRO Market Challenges
2.3.4 Pharmaceutical Development Preclinical CRO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Pharmaceutical Development Preclinical CRO by Players
3.1.1 Global Pharmaceutical Development Preclinical CRO Revenue by Players (2018-2023)
3.1.2 Global Pharmaceutical Development Preclinical CRO Revenue Market Share by Players (2018-2023)
3.2 Global Pharmaceutical Development Preclinical CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Pharmaceutical Development Preclinical CRO, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Pharmaceutical Development Preclinical CRO Market Concentration Ratio
3.4.1 Global Pharmaceutical Development Preclinical CRO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Development Preclinical CRO Revenue in 2022
3.5 Global Key Players of Pharmaceutical Development Preclinical CRO Head office and Area Served
3.6 Global Key Players of Pharmaceutical Development Preclinical CRO, Product and Application
3.7 Global Key Players of Pharmaceutical Development Preclinical CRO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Development Preclinical CRO Breakdown Data by Type
4.1 Global Pharmaceutical Development Preclinical CRO Historic Market Size by Type (2018-2023)
4.2 Global Pharmaceutical Development Preclinical CRO Forecasted Market Size by Type (2024-2033)
5 Pharmaceutical Development Preclinical CRO Breakdown Data by Application
5.1 Global Pharmaceutical Development Preclinical CRO Historic Market Size by Application (2018-2023)
5.2 Global Pharmaceutical Development Preclinical CRO Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Pharmaceutical Development Preclinical CRO Market Size (2018-2033)
6.2 North America Pharmaceutical Development Preclinical CRO Market Size by Type
6.2.1 North America Pharmaceutical Development Preclinical CRO Market Size by Type (2018-2023)
6.2.2 North America Pharmaceutical Development Preclinical CRO Market Size by Type (2024-2033)
6.2.3 North America Pharmaceutical Development Preclinical CRO Market Share by Type (2018-2033)
6.3 North America Pharmaceutical Development Preclinical CRO Market Size by Application
6.3.1 North America Pharmaceutical Development Preclinical CRO Market Size by Application (2018-2023)
6.3.2 North America Pharmaceutical Development Preclinical CRO Market Size by Application (2024-2033)
6.3.3 North America Pharmaceutical Development Preclinical CRO Market Share by Application (2018-2033)
6.4 North America Pharmaceutical Development Preclinical CRO Market Size by Country
6.4.1 North America Pharmaceutical Development Preclinical CRO Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Pharmaceutical Development Preclinical CRO Market Size by Country (2018-2023)
6.4.3 North America Pharmaceutical Development Preclinical CRO Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Pharmaceutical Development Preclinical CRO Market Size (2018-2033)
7.2 Europe Pharmaceutical Development Preclinical CRO Market Size by Type
7.2.1 Europe Pharmaceutical Development Preclinical CRO Market Size by Type (2018-2023)
7.2.2 Europe Pharmaceutical Development Preclinical CRO Market Size by Type (2024-2033)
7.2.3 Europe Pharmaceutical Development Preclinical CRO Market Share by Type (2018-2033)
7.3 Europe Pharmaceutical Development Preclinical CRO Market Size by Application
7.3.1 Europe Pharmaceutical Development Preclinical CRO Market Size by Application (2018-2023)
7.3.2 Europe Pharmaceutical Development Preclinical CRO Market Size by Application (2024-2033)
7.3.3 Europe Pharmaceutical Development Preclinical CRO Market Share by Application (2018-2033)
7.4 Europe Pharmaceutical Development Preclinical CRO Market Size by Country
7.4.1 Europe Pharmaceutical Development Preclinical CRO Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Pharmaceutical Development Preclinical CRO Market Size by Country (2018-2023)
7.4.3 Europe Pharmaceutical Development Preclinical CRO Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Pharmaceutical Development Preclinical CRO Market Size (2018-2033)
8.2 China Pharmaceutical Development Preclinical CRO Market Size by Type
8.2.1 China Pharmaceutical Development Preclinical CRO Market Size by Type (2018-2023)
8.2.2 China Pharmaceutical Development Preclinical CRO Market Size by Type (2024-2033)
8.2.3 China Pharmaceutical Development Preclinical CRO Market Share by Type (2018-2033)
8.3 China Pharmaceutical Development Preclinical CRO Market Size by Application
8.3.1 China Pharmaceutical Development Preclinical CRO Market Size by Application (2018-2023)
8.3.2 China Pharmaceutical Development Preclinical CRO Market Size by Application (2024-2033)
8.3.3 China Pharmaceutical Development Preclinical CRO Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Pharmaceutical Development Preclinical CRO Market Size (2018-2033)
9.2 Asia Pharmaceutical Development Preclinical CRO Market Size by Type
9.2.1 Asia Pharmaceutical Development Preclinical CRO Market Size by Type (2018-2023)
9.2.2 Asia Pharmaceutical Development Preclinical CRO Market Size by Type (2024-2033)
9.2.3 Asia Pharmaceutical Development Preclinical CRO Market Share by Type (2018-2033)
9.3 Asia Pharmaceutical Development Preclinical CRO Market Size by Application
9.3.1 Asia Pharmaceutical Development Preclinical CRO Market Size by Application (2018-2023)
9.3.2 Asia Pharmaceutical Development Preclinical CRO Market Size by Application (2024-2033)
9.3.3 Asia Pharmaceutical Development Preclinical CRO Market Share by Application (2018-2033)
9.4 Asia Pharmaceutical Development Preclinical CRO Market Size by Region
9.4.1 Asia Pharmaceutical Development Preclinical CRO Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Pharmaceutical Development Preclinical CRO Market Size by Region (2018-2023)
9.4.3 Asia Pharmaceutical Development Preclinical CRO Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Pharmaceutical Development Preclinical CRO Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Pharmaceutical Development Preclinical CRO Market Size by Type
10.2.1 Middle East, Africa, and Latin America Pharmaceutical Development Preclinical CRO Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Pharmaceutical Development Preclinical CRO Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Pharmaceutical Development Preclinical CRO Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Pharmaceutical Development Preclinical CRO Market Size by Application
10.3.1 Middle East, Africa, and Latin America Pharmaceutical Development Preclinical CRO Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Pharmaceutical Development Preclinical CRO Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Pharmaceutical Development Preclinical CRO Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Pharmaceutical Development Preclinical CRO Market Size by Country
10.4.1 Middle East, Africa, and Latin America Pharmaceutical Development Preclinical CRO Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Pharmaceutical Development Preclinical CRO Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Pharmaceutical Development Preclinical CRO Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Details
11.1.2 Charles River Business Overview
11.1.3 Charles River Pharmaceutical Development Preclinical CRO Introduction
11.1.4 Charles River Revenue in Pharmaceutical Development Preclinical CRO Business (2018-2023)
11.1.5 Charles River Recent Developments
11.2 Wuxi AppTec
11.2.1 Wuxi AppTec Company Details
11.2.2 Wuxi AppTec Business Overview
11.2.3 Wuxi AppTec Pharmaceutical Development Preclinical CRO Introduction
11.2.4 Wuxi AppTec Revenue in Pharmaceutical Development Preclinical CRO Business (2018-2023)
11.2.5 Wuxi AppTec Recent Developments
11.3 Labcorp
11.3.1 Labcorp Company Details
11.3.2 Labcorp Business Overview
11.3.3 Labcorp Pharmaceutical Development Preclinical CRO Introduction
11.3.4 Labcorp Revenue in Pharmaceutical Development Preclinical CRO Business (2018-2023)
11.3.5 Labcorp Recent Developments
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Details
11.4.2 Eurofins Scientific Business Overview
11.4.3 Eurofins Scientific Pharmaceutical Development Preclinical CRO Introduction
11.4.4 Eurofins Scientific Revenue in Pharmaceutical Development Preclinical CRO Business (2018-2023)
11.4.5 Eurofins Scientific Recent Developments
11.5 PPD, Inc.
11.5.1 PPD, Inc. Company Details
11.5.2 PPD, Inc. Business Overview
11.5.3 PPD, Inc. Pharmaceutical Development Preclinical CRO Introduction
11.5.4 PPD, Inc. Revenue in Pharmaceutical Development Preclinical CRO Business (2018-2023)
11.5.5 PPD, Inc. Recent Developments
11.6 ICON Plc.
11.6.1 ICON Plc. Company Details
11.6.2 ICON Plc. Business Overview
11.6.3 ICON Plc. Pharmaceutical Development Preclinical CRO Introduction
11.6.4 ICON Plc. Revenue in Pharmaceutical Development Preclinical CRO Business (2018-2023)
11.6.5 ICON Plc. Recent Developments
11.7 Pharmaron
11.7.1 Pharmaron Company Details
11.7.2 Pharmaron Business Overview
11.7.3 Pharmaron Pharmaceutical Development Preclinical CRO Introduction
11.7.4 Pharmaron Revenue in Pharmaceutical Development Preclinical CRO Business (2018-2023)
11.7.5 Pharmaron Recent Developments
11.8 Inotiv
11.8.1 Inotiv Company Details
11.8.2 Inotiv Business Overview
11.8.3 Inotiv Pharmaceutical Development Preclinical CRO Introduction
11.8.4 Inotiv Revenue in Pharmaceutical Development Preclinical CRO Business (2018-2023)
11.8.5 Inotiv Recent Developments
11.9 ChemPartner
11.9.1 ChemPartner Company Details
11.9.2 ChemPartner Business Overview
11.9.3 ChemPartner Pharmaceutical Development Preclinical CRO Introduction
11.9.4 ChemPartner Revenue in Pharmaceutical Development Preclinical CRO Business (2018-2023)
11.9.5 ChemPartner Recent Developments
11.10 JOINN Lab
11.10.1 JOINN Lab Company Details
11.10.2 JOINN Lab Business Overview
11.10.3 JOINN Lab Pharmaceutical Development Preclinical CRO Introduction
11.10.4 JOINN Lab Revenue in Pharmaceutical Development Preclinical CRO Business (2018-2023)
11.10.5 JOINN Lab Recent Developments
11.11 EVOTEC
11.11.1 EVOTEC Company Details
11.11.2 EVOTEC Business Overview
11.11.3 EVOTEC Pharmaceutical Development Preclinical CRO Introduction
11.11.4 EVOTEC Revenue in Pharmaceutical Development Preclinical CRO Business (2018-2023)
11.11.5 EVOTEC Recent Developments
11.12 Medicilon
11.12.1 Medicilon Company Details
11.12.2 Medicilon Business Overview
11.12.3 Medicilon Pharmaceutical Development Preclinical CRO Introduction
11.12.4 Medicilon Revenue in Pharmaceutical Development Preclinical CRO Business (2018-2023)
11.12.5 Medicilon Recent Developments
11.13 Crown Bioscience
11.13.1 Crown Bioscience Company Details
11.13.2 Crown Bioscience Business Overview
11.13.3 Crown Bioscience Pharmaceutical Development Preclinical CRO Introduction
11.13.4 Crown Bioscience Revenue in Pharmaceutical Development Preclinical CRO Business (2018-2023)
11.13.5 Crown Bioscience Recent Developments
11.14 Champion Oncology
11.14.1 Champion Oncology Company Details
11.14.2 Champion Oncology Business Overview
11.14.3 Champion Oncology Pharmaceutical Development Preclinical CRO Introduction
11.14.4 Champion Oncology Revenue in Pharmaceutical Development Preclinical CRO Business (2018-2023)
11.14.5 Champion Oncology Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Pharmaceutical Development Preclinical CRO Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Bioanalysis and DMPK Studies
Table 3. Key Players of Toxicology Testing
Table 4. Key Players of Safety Pharmacology
Table 5. Key Players of Others
Table 6. Global Pharmaceutical Development Preclinical CRO Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 7. Global Pharmaceutical Development Preclinical CRO Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Pharmaceutical Development Preclinical CRO Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Pharmaceutical Development Preclinical CRO Market Share by Region (2018-2023)
Table 10. Global Pharmaceutical Development Preclinical CRO Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Pharmaceutical Development Preclinical CRO Market Share by Region (2024-2033)
Table 12. Pharmaceutical Development Preclinical CRO Market Trends
Table 13. Pharmaceutical Development Preclinical CRO Market Drivers
Table 14. Pharmaceutical Development Preclinical CRO Market Challenges
Table 15. Pharmaceutical Development Preclinical CRO Market Restraints
Table 16. Global Pharmaceutical Development Preclinical CRO Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Pharmaceutical Development Preclinical CRO Revenue Share by Players (2018-2023)
Table 18. Global Top Pharmaceutical Development Preclinical CRO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Development Preclinical CRO as of 2022)
Table 19. Global Pharmaceutical Development Preclinical CRO Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by Pharmaceutical Development Preclinical CRO Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of Pharmaceutical Development Preclinical CRO, Headquarters and Area Served
Table 22. Global Key Players of Pharmaceutical Development Preclinical CRO, Product and Application
Table 23. Global Key Players of Pharmaceutical Development Preclinical CRO, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pharmaceutical Development Preclinical CRO Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Pharmaceutical Development Preclinical CRO Revenue Market Share by Type (2018-2023)
Table 27. Global Pharmaceutical Development Preclinical CRO Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Pharmaceutical Development Preclinical CRO Revenue Market Share by Type (2024-2033)
Table 29. Global Pharmaceutical Development Preclinical CRO Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Pharmaceutical Development Preclinical CRO Revenue Share by Application (2018-2023)
Table 31. Global Pharmaceutical Development Preclinical CRO Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Pharmaceutical Development Preclinical CRO Revenue Share by Application (2024-2033)
Table 33. North America Pharmaceutical Development Preclinical CRO Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America Pharmaceutical Development Preclinical CRO Market Size by Type (2024-2033) & (US$ Million)
Table 35. North America Pharmaceutical Development Preclinical CRO Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America Pharmaceutical Development Preclinical CRO Market Size by Application (2024-2033) & (US$ Million)
Table 37. North America Pharmaceutical Development Preclinical CRO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. North America Pharmaceutical Development Preclinical CRO Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Pharmaceutical Development Preclinical CRO Market Size by Country (2024-2033) & (US$ Million)
Table 40. Europe Pharmaceutical Development Preclinical CRO Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe Pharmaceutical Development Preclinical CRO Market Size by Type (2024-2033) & (US$ Million)
Table 42. Europe Pharmaceutical Development Preclinical CRO Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe Pharmaceutical Development Preclinical CRO Market Size by Application (2024-2033) & (US$ Million)
Table 44. Europe Pharmaceutical Development Preclinical CRO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Europe Pharmaceutical Development Preclinical CRO Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe Pharmaceutical Development Preclinical CRO Market Size by Country (2024-2033) & (US$ Million)
Table 47. China Pharmaceutical Development Preclinical CRO Market Size by Type (2018-2023) & (US$ Million)
Table 48. China Pharmaceutical Development Preclinical CRO Market Size by Type (2024-2033) & (US$ Million)
Table 49. China Pharmaceutical Development Preclinical CRO Market Size by Application (2018-2023) & (US$ Million)
Table 50. China Pharmaceutical Development Preclinical CRO Market Size by Application (2024-2033) & (US$ Million)
Table 51. Asia Pharmaceutical Development Preclinical CRO Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia Pharmaceutical Development Preclinical CRO Market Size by Type (2024-2033) & (US$ Million)
Table 53. Asia Pharmaceutical Development Preclinical CRO Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia Pharmaceutical Development Preclinical CRO Market Size by Application (2024-2033) & (US$ Million)
Table 55. Asia Pharmaceutical Development Preclinical CRO Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 56. Asia Pharmaceutical Development Preclinical CRO Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia Pharmaceutical Development Preclinical CRO Market Size by Region (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Pharmaceutical Development Preclinical CRO Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Pharmaceutical Development Preclinical CRO Market Size by Type (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Pharmaceutical Development Preclinical CRO Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Pharmaceutical Development Preclinical CRO Market Size by Application (2024-2033) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Pharmaceutical Development Preclinical CRO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 63. Middle East, Africa, and Latin America Pharmaceutical Development Preclinical CRO Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Pharmaceutical Development Preclinical CRO Market Size by Country (2024-2033) & (US$ Million)
Table 65. Charles River Company Details
Table 66. Charles River Business Overview
Table 67. Charles River Pharmaceutical Development Preclinical CRO Product
Table 68. Charles River Revenue in Pharmaceutical Development Preclinical CRO Business (2018-2023) & (US$ Million)
Table 69. Charles River Recent Developments
Table 70. Wuxi AppTec Company Details
Table 71. Wuxi AppTec Business Overview
Table 72. Wuxi AppTec Pharmaceutical Development Preclinical CRO Product
Table 73. Wuxi AppTec Revenue in Pharmaceutical Development Preclinical CRO Business (2018-2023) & (US$ Million)
Table 74. Wuxi AppTec Recent Developments
Table 75. Labcorp Company Details
Table 76. Labcorp Business Overview
Table 77. Labcorp Pharmaceutical Development Preclinical CRO Product
Table 78. Labcorp Revenue in Pharmaceutical Development Preclinical CRO Business (2018-2023) & (US$ Million)
Table 79. Labcorp Recent Developments
Table 80. Eurofins Scientific Company Details
Table 81. Eurofins Scientific Business Overview
Table 82. Eurofins Scientific Pharmaceutical Development Preclinical CRO Product
Table 83. Eurofins Scientific Revenue in Pharmaceutical Development Preclinical CRO Business (2018-2023) & (US$ Million)
Table 84. Eurofins Scientific Recent Developments
Table 85. PPD, Inc. Company Details
Table 86. PPD, Inc. Business Overview
Table 87. PPD, Inc. Pharmaceutical Development Preclinical CRO Product
Table 88. PPD, Inc. Revenue in Pharmaceutical Development Preclinical CRO Business (2018-2023) & (US$ Million)
Table 89. PPD, Inc. Recent Developments
Table 90. ICON Plc. Company Details
Table 91. ICON Plc. Business Overview
Table 92. ICON Plc. Pharmaceutical Development Preclinical CRO Product
Table 93. ICON Plc. Revenue in Pharmaceutical Development Preclinical CRO Business (2018-2023) & (US$ Million)
Table 94. ICON Plc. Recent Developments
Table 95. Pharmaron Company Details
Table 96. Pharmaron Business Overview
Table 97. Pharmaron Pharmaceutical Development Preclinical CRO Product
Table 98. Pharmaron Revenue in Pharmaceutical Development Preclinical CRO Business (2018-2023) & (US$ Million)
Table 99. Pharmaron Recent Developments
Table 100. Inotiv Company Details
Table 101. Inotiv Business Overview
Table 102. Inotiv Pharmaceutical Development Preclinical CRO Product
Table 103. Inotiv Revenue in Pharmaceutical Development Preclinical CRO Business (2018-2023) & (US$ Million)
Table 104. Inotiv Recent Developments
Table 105. ChemPartner Company Details
Table 106. ChemPartner Business Overview
Table 107. ChemPartner Pharmaceutical Development Preclinical CRO Product
Table 108. ChemPartner Revenue in Pharmaceutical Development Preclinical CRO Business (2018-2023) & (US$ Million)
Table 109. ChemPartner Recent Developments
Table 110. JOINN Lab Company Details
Table 111. JOINN Lab Business Overview
Table 112. JOINN Lab Pharmaceutical Development Preclinical CRO Product
Table 113. JOINN Lab Revenue in Pharmaceutical Development Preclinical CRO Business (2018-2023) & (US$ Million)
Table 114. JOINN Lab Recent Developments
Table 115. EVOTEC Company Details
Table 116. EVOTEC Business Overview
Table 117. EVOTEC Pharmaceutical Development Preclinical CRO Product
Table 118. EVOTEC Revenue in Pharmaceutical Development Preclinical CRO Business (2018-2023) & (US$ Million)
Table 119. EVOTEC Recent Developments
Table 120. Medicilon Company Details
Table 121. Medicilon Business Overview
Table 122. Medicilon Pharmaceutical Development Preclinical CRO Product
Table 123. Medicilon Revenue in Pharmaceutical Development Preclinical CRO Business (2018-2023) & (US$ Million)
Table 124. Medicilon Recent Developments
Table 125. Crown Bioscience Company Details
Table 126. Crown Bioscience Business Overview
Table 127. Crown Bioscience Pharmaceutical Development Preclinical CRO Product
Table 128. Crown Bioscience Revenue in Pharmaceutical Development Preclinical CRO Business (2018-2023) & (US$ Million)
Table 129. Crown Bioscience Recent Developments
Table 130. Champion Oncology Company Details
Table 131. Champion Oncology Business Overview
Table 132. Champion Oncology Pharmaceutical Development Preclinical CRO Product
Table 133. Champion Oncology Revenue in Pharmaceutical Development Preclinical CRO Business (2018-2023) & (US$ Million)
Table 134. Champion Oncology Recent Developments
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmaceutical Development Preclinical CRO Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Pharmaceutical Development Preclinical CRO Market Share by Type: 2022 VS 2033
Figure 3. Bioanalysis and DMPK Studies Features
Figure 4. Toxicology Testing Features
Figure 5. Safety Pharmacology Features
Figure 6. Others Features
Figure 7. Global Pharmaceutical Development Preclinical CRO Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 8. Global Pharmaceutical Development Preclinical CRO Market Share by Application: 2022 VS 2033
Figure 9. Small and Medium Pharmaceutical Company Case Studies
Figure 10. Large Pharmaceutical Company Case Studies
Figure 11. Pharmaceutical Development Preclinical CRO Report Years Considered
Figure 12. Global Pharmaceutical Development Preclinical CRO Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Pharmaceutical Development Preclinical CRO Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Pharmaceutical Development Preclinical CRO Market Share by Region: 2022 VS 2033
Figure 15. Global Pharmaceutical Development Preclinical CRO Market Share by Players in 2022
Figure 16. Global Top Pharmaceutical Development Preclinical CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Development Preclinical CRO as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Pharmaceutical Development Preclinical CRO Revenue in 2022
Figure 18. North America Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Pharmaceutical Development Preclinical CRO Market Share by Type (2018-2033)
Figure 20. North America Pharmaceutical Development Preclinical CRO Market Share by Application (2018-2033)
Figure 21. North America Pharmaceutical Development Preclinical CRO Market Share by Country (2018-2033)
Figure 22. United States Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Pharmaceutical Development Preclinical CRO Market Size YoY (2018-2033) & (US$ Million)
Figure 25. Europe Pharmaceutical Development Preclinical CRO Market Share by Type (2018-2033)
Figure 26. Europe Pharmaceutical Development Preclinical CRO Market Share by Application (2018-2033)
Figure 27. Europe Pharmaceutical Development Preclinical CRO Market Share by Country (2018-2033)
Figure 28. Germany Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. China Pharmaceutical Development Preclinical CRO Market Size YoY (2018-2033) & (US$ Million)
Figure 35. China Pharmaceutical Development Preclinical CRO Market Share by Type (2018-2033)
Figure 36. China Pharmaceutical Development Preclinical CRO Market Share by Application (2018-2033)
Figure 37. Asia Pharmaceutical Development Preclinical CRO Market Size YoY (2018-2033) & (US$ Million)
Figure 38. Asia Pharmaceutical Development Preclinical CRO Market Share by Type (2018-2033)
Figure 39. Asia Pharmaceutical Development Preclinical CRO Market Share by Application (2018-2033)
Figure 40. Asia Pharmaceutical Development Preclinical CRO Market Share by Region (2018-2033)
Figure 41. Japan Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. South Korea Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. China Taiwan Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Southeast Asia Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. India Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Australia Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Pharmaceutical Development Preclinical CRO Market Size YoY (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Pharmaceutical Development Preclinical CRO Market Share by Type (2018-2033)
Figure 49. Middle East, Africa, and Latin America Pharmaceutical Development Preclinical CRO Market Share by Application (2018-2033)
Figure 50. Middle East, Africa, and Latin America Pharmaceutical Development Preclinical CRO Market Share by Country (2018-2033)
Figure 51. Brazil Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Mexico Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Turkey Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Saudi Arabia Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Israel Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. GCC Countries Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Charles River Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2018-2023)
Figure 58. Wuxi AppTec Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2018-2023)
Figure 59. Labcorp Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2018-2023)
Figure 60. Eurofins Scientific Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2018-2023)
Figure 61. PPD, Inc. Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2018-2023)
Figure 62. ICON Plc. Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2018-2023)
Figure 63. Pharmaron Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2018-2023)
Figure 64. Inotiv Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2018-2023)
Figure 65. ChemPartner Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2018-2023)
Figure 66. JOINN Lab Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2018-2023)
Figure 67. EVOTEC Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2018-2023)
Figure 68. Medicilon Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2018-2023)
Figure 69. Crown Bioscience Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2018-2023)
Figure 70. Champion Oncology Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2018-2023)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries